March 4, 2024 11:31 AM ESTUpdated March 5, 01:30 PM
Law

Drug­mak­ers sub­mit coun­terof­fers as part of first round of drug price ne­go­ti­a­tions

Zachary Brennan

Senior Editor

The Biden Ad­min­is­tra­tion on Mon­day con­tin­ued to tout its ef­forts to low­er drug prices, not­ing in a state­ment ahead of a like­ly drug-pric­ing-heavy State of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times